Zhenhai Lu

6PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 19, 2026
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial.

Wei-Jian Mei, Xiao-Zhong Wang, Xuan Zhang

|Jul 24, 2025
Short-Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.

Rongxin Zhang, Fulong Wang, Xinhua Jiang

|Jul 04, 2025
Delayed surgery for more than 9 weeks induces worse survival outcomes in locally advanced rectal cancer patients with poor response to neoadjuvant chemoradiotherapy: a propensity score matched cohort study.

Hao Wang, Yuan Li, Xinyu Ge

|Jun 04, 2024
Correction to: Efficacy and Safety of Neoadjuvant Subcutaneous Envafolimab in dMMR/MSI-H Locally Advanced Colon Cancer.

Yuan Li, Weili Zhang, Jie Du

|May 10, 2024
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.

De-Shen Wang, Chao Ren, Shan-Shan Li

|May 01, 2024
Efficacy and Safety of Neoadjuvant Subcutaneous Envafolimab in dMMR/MSI-H Locally Advanced Colon Cancer.

Yuan Li, Weili Zhang, Jie Du

Pageof 1

Frequent Collaborators

2 joint publications

Weili Zhang

1 joint publications

De-Shen Wang

1 joint publications

Xiao-Jun Wu

1 joint publications

Jian Xiao